AAAAAA

   
Results: 1-10 |
Results: 10
Pharmacogenetics of warfarin elimination and its clinical implications
Authors: Takahashi, H Echizen, H
Citation: H. Takahashi et H. Echizen, Pharmacogenetics of warfarin elimination and its clinical implications, CLIN PHARMA, 40(8), 2001, pp. 587-603
No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients
Authors: Okumura, H Nishimura, E Kariya, S Ohtani, M Uchino, K Fukatsu, T Odanaka, J Takahashi, T Watanabe, K Itoh, T Hashiguchi, M Echizen, H Rikihisa, T
Citation: H. Okumura et al., No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients, YAKUGAKU ZA, 121(3), 2001, pp. 253-257
Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits
Authors: Miwa, J Echizen, H Matsueda, K Umeda, N
Citation: J. Miwa et al., Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits, DIGESTION, 63(3), 2001, pp. 188-194
Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylationof disopyramide enantiomers in humans
Authors: Echizen, H Tanizaki, M Tatsuno, J Chiba, K Berwick, T Tani, M Gonzalez, FJ Ishizaki, T
Citation: H. Echizen et al., Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylationof disopyramide enantiomers in humans, DRUG META D, 28(8), 2000, pp. 937-944
Developmental changes in pharmacokinetics and pharmacodynamics of warfarinenantiomers in Japanese children
Authors: Takahashi, H Ishikawa, S Nomoto, S Nishigaki, Y Ando, F Kashima, T Kimura, S Kanamori, M Echizen, H
Citation: H. Takahashi et al., Developmental changes in pharmacokinetics and pharmacodynamics of warfarinenantiomers in Japanese children, CLIN PHARM, 68(5), 2000, pp. 541-555
Active oxygen species generation and cellular damage by additives of parenteral preparations: Selenium and sulfhydryl compounds
Authors: Terada, A Yoshida, M Seko, Y Kobayashi, T Yoshida, K Nakada, M Nakada, K Echizen, H Ogata, H Rikihisa, T
Citation: A. Terada et al., Active oxygen species generation and cellular damage by additives of parenteral preparations: Selenium and sulfhydryl compounds, NUTRITION, 15(9), 1999, pp. 651-655
Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: Application of in vitro approaches to predicting in vivo reduction of (S)-warfarin clearance
Authors: Takahashi, H Kashima, T Kimura, S Murata, N Takaba, T Iwade, K Abe, T Tainaka, H Yasumori, T Echizen, H
Citation: H. Takahashi et al., Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: Application of in vitro approaches to predicting in vivo reduction of (S)-warfarin clearance, DRUG META D, 27(10), 1999, pp. 1179-1186
Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions
Authors: Sekine, Y Rikihisa, T Ogata, H Echizen, H Arakawa, Y
Citation: Y. Sekine et al., Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions, EUR J CL PH, 55(8), 1999, pp. 583-587
Effects of oral supplementation with evening primrose oil for six weeks onplasma essential fatty acids and uremic skin symptoms in hemodialysis patients
Authors: Yoshimoto-Furuie, K Yoshimoto, K Tanaka, T Saima, S Kikuchi, Y Shay, J Horrobin, DF Echizen, H
Citation: K. Yoshimoto-furuie et al., Effects of oral supplementation with evening primrose oil for six weeks onplasma essential fatty acids and uremic skin symptoms in hemodialysis patients, NEPHRON, 81(2), 1999, pp. 151-159
Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone
Authors: Takahashi, H Sato, T Shimoyama, Y Shioda, N Shimizu, T Kubo, S Tamura, N Tainaka, H Yasumori, T Echizen, H
Citation: H. Takahashi et al., Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone, CLIN PHARM, 66(6), 1999, pp. 569-581
Risultati: 1-10 |